27.51
price down icon1.09%   -0.12
 
loading
Instil Bio Inc stock is traded at $27.51, with a volume of 46,936. It is down -1.09% in the last 24 hours and down -43.63% over the past month. Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$27.63
Open:
$27.05
24h Volume:
46,936
Relative Volume:
0.18
Market Cap:
$182.04M
Revenue:
-
Net Income/Loss:
$-156.09M
P/E Ratio:
-19.37
EPS:
-1.42
Net Cash Flow:
$-102.69M
1W Performance:
-20.58%
1M Performance:
-43.63%
6M Performance:
+141.86%
1Y Performance:
+7,188%
1-Day Range:
Value
$26.46
$28.19
1-Week Range:
Value
$26.46
$34.84
52-Week Range:
Value
$0.3035
$92.00

Instil Bio Inc Stock (TIL) Company Profile

Name
Name
Instil Bio Inc
Name
Phone
(972) 499-3350
Name
Address
3963 MAPLE AVENUE, DALLAS
Name
Employee
49
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
TIL's Discussions on Twitter

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-01-22 Downgrade Cowen Outperform → Market Perform
Nov-01-22 Downgrade Truist Buy → Hold
Aug-13-21 Initiated Robert W. Baird Outperform
Apr-13-21 Initiated Cowen Outperform
Apr-13-21 Initiated Morgan Stanley Equal-Weight
Apr-13-21 Initiated Truist Buy
View All

Instil Bio Inc Stock (TIL) Latest News

pulisher
Nov 04, 2024

JMP Securities initiates Instil Bio shares at Market Perform on public offering - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Instil Bio, Inc.'s (NASDAQ:TIL) stock price dropped 18% last week; private equity firms would not be happy - Simply Wall St

Nov 04, 2024
pulisher
Oct 24, 2024

Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? - The Motley Fool

Oct 24, 2024
pulisher
Oct 23, 2024

Analysis of Curative Ventures V LLC's Strategic Reduction in Instil Bio Inc - Yahoo Finance

Oct 23, 2024
pulisher
Oct 11, 2024

Baird maintains price target on Instil Bio stock, stays upbeat - Investing.com

Oct 11, 2024
pulisher
Oct 08, 2024

5 Top NASDAQ Biotech Stocks of 2024 - Nasdaq

Oct 08, 2024
pulisher
Oct 04, 2024

(TIL) Trading Report - Stock Traders Daily

Oct 04, 2024
pulisher
Sep 29, 2024

Instil Bio Stock Skyrockets 641% in One Week: Here's Why - MSN

Sep 29, 2024
pulisher
Sep 28, 2024

BOXER CAPITAL, LLC Acquires New Stake in Instil Bio Inc - GuruFocus.com

Sep 28, 2024
pulisher
Sep 27, 2024

Perceptive Advisors LLC Acquires New Stake in Instil Bio Inc - GuruFocus.com

Sep 27, 2024
pulisher
Sep 25, 2024

2 Stocks Up Over 700% in 2024 That Could Soar Even Further - MSN

Sep 25, 2024
pulisher
Sep 24, 2024

(TIL) Long Term Investment Analysis - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 20, 2024

Baird sees Instil Bio stock upside on promising SYN-2510 clinical data - Investing.com

Sep 20, 2024
pulisher
Sep 19, 2024

Fantastic Fest 2024: Clowns Rule at Texas’ No-Joke Genre Event Set to Debut ‘Terrifier 3,’ ‘V/H/S Beyond,’ and More - IndieWire

Sep 19, 2024
pulisher
Sep 19, 2024

B. Riley Analysts Decrease Earnings Estimates for Inspired Entertainment, Inc. (NASDAQ:INSE) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

The time has not yet come to remove your chips from the table: Instil Bio Inc (TIL) - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Financial Metrics Unveiled: Instil Bio Inc (TIL)’s Key Ratios in the Spotlight - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Instil Bio (TIL) Stock Rises In Extended Session On Major Strategy Reveal - Stocks Telegraph

Sep 18, 2024
pulisher
Sep 18, 2024

Inspired Entertainment, Inc. to Post Q3 2024 Earnings of $0.22 Per Share, B. Riley Forecasts (NASDAQ:INSE) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Ice Nine Kills to Release Official Song for Slasher Film Terrifier 3 - MetalSucks

Sep 17, 2024
pulisher
Sep 17, 2024

Baird retains price target, outperform rating on Instil Bio shares By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Ice Nine Kills are releasing a new single for Terrifier 3 - Kerrang!

Sep 17, 2024
pulisher
Sep 17, 2024

Ice Nine Kills’ Upcoming Single “A Work of Art” to Feature on "Terrifier 3" Soundtrack - Ghost Cult Magazine

Sep 17, 2024
pulisher
Sep 17, 2024

Here's Why Everyone's Talking About Summit Therapeutics - MSN

Sep 17, 2024
pulisher
Sep 17, 2024

This is why everyone is talking about Summit TherapeuticsTHE BHARAT EXPRESS NEWS - The Bharat Express News

Sep 17, 2024
pulisher
Sep 17, 2024

Instil Bio stock target raised by H.C. Wainwright on cancer drug outlook - Investing.com

Sep 17, 2024
pulisher
Sep 17, 2024

instilbiocorppres2024091.htm - SEC.gov

Sep 17, 2024
pulisher
Sep 16, 2024

ICE NINE KILLS announce new 'TERRIFIER'-themed single and video starring SHAVO ODADJIAN - Revolver Magazine

Sep 16, 2024
pulisher
Sep 16, 2024

Official 'Terrifier 3' Music Video from Ice Nine Kills Slashing into Fantastic Fest & AMC Theatres! - Bloody Disgusting

Sep 16, 2024
pulisher
Sep 16, 2024

Crude Oil Surges Over 1%; Instil Bio Shares Plunge - MSN

Sep 16, 2024
pulisher
Sep 16, 2024

Baird retains price target, outperform rating on Instil Bio shares - Investing.com India

Sep 16, 2024
pulisher
Sep 16, 2024

Instil Bio Inc (TIL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Baird positive on Instil Bio’s SYN-2510 development strategy - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

Do investors need to be concerned about Instil Bio Inc (TIL)? - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Instil Bio Outlines Oncology Strategy and Collaborative Efforts - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

Instil Bio price target raised to $120 from $40 at H.C. Wainwright - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer - Yahoo Finance

Sep 16, 2024
pulisher
Sep 14, 2024

Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - sharewise

Sep 14, 2024
pulisher
Sep 13, 2024

Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com India

Sep 13, 2024
pulisher
Sep 13, 2024

Summit lifts Instil, BioNTech on Merck beating data (NASDAQ:SMMT) - Seeking Alpha

Sep 13, 2024
pulisher
Sep 13, 2024

Instil Bio: PD-L1/VEGF Bispecific Targeting With Unique Enhancements (TIL) - Seeking Alpha

Sep 13, 2024
pulisher
Sep 13, 2024

Instil Bio surges after Baird target calls for shares tripling - TipRanks

Sep 13, 2024
pulisher
Sep 13, 2024

(TIL) On The My Stocks Page - Stock Traders Daily

Sep 13, 2024
pulisher
Sep 13, 2024

Instil Bio’s Stock Price Target (NASDAQ: TIL) Get’s A Big Uplift From Baird - AskTraders

Sep 13, 2024
pulisher
Sep 13, 2024

H.C. Wainwright raises Instil Bio shares target with Buy rating By Investing.com - Investing.com Australia

Sep 13, 2024
pulisher
Sep 13, 2024

Instil Bio price target raised to $180 from $32 at Baird - TipRanks

Sep 13, 2024
pulisher
Sep 12, 2024

H.C. Wainwright raises share target for Instil Bio by US$15 - Mugglehead

Sep 12, 2024
pulisher
Sep 12, 2024

H.C. Wainwright raises Instil Bio shares target with Buy rating - Investing.com

Sep 12, 2024
pulisher
Sep 12, 2024

Instil Bio Surges After Another Price-Target Boost - MarketWatch

Sep 12, 2024
pulisher
Sep 12, 2024

Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal - BP Journal

Sep 12, 2024
pulisher
Sep 12, 2024

Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors - BP Journal

Sep 12, 2024

Instil Bio Inc Stock (TIL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):